Skip to main content Back to Top


Major Company to Stop Making Generic Oral Products

Cheryl A. Thompson

American Home Products Corp. (AHP) has announced that it will stop manufacturing and marketing generic oral drug products over the next several months. The company's generic pharmaceuticals are made by ESI Lederle Inc., a division of Wyeth-Ayerst Laboratories, AHP's pharmaceuticals branch.

According to a "Dear Customer" letter dated July 17, the company will discontinue manufacturing the following generic tablets and capsules: acyclovir, atenolol, bisoprolol fumarate (with or without hydrochlorothiazide), clonidine hydrochloride, etodolac, guanfacine hydrochloride, hydrochlorothiazide, ketoprofen, lorazepam, methazolamide, methocarbamol, methotrexate sodium, metoclopramide hydrochloride, minocycline hydrochloride, pentoxifylline, oxazepam, propranolol hydrochloride, pyrazinamide, quinidine sulfate, and selegiline hydrochloride. The products bear the National Drug Code number for ESI Pharma Inc. (59911) or Lederle Laboratories (00005).

Half of the generic drug products targeted for discontinuation are available as brand-name products from Wyeth-Ayerst.